Closed

Hemorrhage Detection Technology

Medical Technology Enterprise Consortium (MTEC)

REQUEST ISSUE DATE

November 06, 2019

DUE DATE

December 06, 2019

Awardees

Member

Henry M. Jackson Foundation for the Advancement of Military Medicine

The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) is dedicated to advancing military medicine through research and innovation. For over 40 years, HJF has been a trusted partner in managing research awards, ensuring compliance, and facilitating the transition of medical innovations from concept to commercialization. The foundation supports a wide range of research areas, including infectious diseases, cancer, and mental health, with a focus on improving the health and readiness of military personnel and civilians alike.

Funding (ceiling)

$977,918.74

Member

Applied Research Associates, Inc. (ARA)

Applied Research Associates, Inc. (ARA) is a globally recognized scientific research and engineering company dedicated to solving critical national problems to improve safety, security, and quality of life. Founded in 1979, ARA is 100% employee-owned and offers innovative technologies and solutions across various sectors, including national security, infrastructure, health solutions, and energy and environment. The company is committed to delivering mission-critical solutions that exceed expectations and lead to new possibilities.

Funding (ceiling)

$1,807,762.84

View All 3 Awardees

Purpose

This solicitation, issued by MTEC, represents a Request for Project Proposals (RPP) for MTEC support of the U.S. Army Medical Materiel Development Activity (USAMMDA). The award(s) will be managed by the Warfighter Expeditionary Medicine and Treatment (W-EMT) Project Management Office (PMO). The Hemorrhage Detection Integrated Product Team (IPT) will provide consultative input into the project as needed, and conduct annual in-progress reviews with the Milestone Decision Authority, as well as interim reviews if needed more frequently.

This Request for Project Proposals (RPP) is focused on the development of a noninvasive technology for early diagnosis and provider alert of decompensation due to hemorrhage and hemorrhagic shock in order to inform earlier lifesaving interventions and improve patient outcomes (see Section 2 for more detail).

Scope of Work

Project Scope and Potential for Follow-on Work:

The initial 12-month delivery schedule should be focused on tasks relevant to prototype development through proof of concept in a clinical study or system prototype demonstration in a relevant or operational environment for detection of decompensation due to hemorrhage and hemorrhagic shock. Allowable costs include subject matter expertise, consultation to develop a regulatory strategy, testing and evaluation, and clinical trial support. Potential follow-on work in subsequent years may be awarded to continue product development toward additional human clinical trial(s) and relevant FDA clearance/approval.